Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic fabry disease cardiomyopathy.

Back

ESC Professional Premium Access

Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic fabry disease cardiomyopathy.

Session: New insights into pharmacotherapy for acute heart failure

Topic: Pathophysiology and Mechanisms

Speaker: Doctor C. Chimenti (Rome, IT)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Cristina Chimenti

Sapienza University of Rome, Rome (Italy)

0 follower

7 more presentations in this session

Spectrum of heart failure in 16 sub-saharan countries: drugs strategies and 8-year trends (the february study 2016-2023)

Speaker: Professor I. Diop (Dakar, SN)

Combination of diuretics to overcome diuretic resistance in acute heart failure: systematic review and updated network meta-analysis

Speaker: Doctor I. Cunha (Sao Paulo, BR)

Effect of renin-angiotensin system inhibitors in elderly patients with heart failure and reduced ejection fraction

Speaker: Doctor Y. Tamaki (Tenri, JP)

REDUCE-HF: a stronger heart go a long way

Speaker: Doctor K. Kam (Sha Tin, HK)

Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

Speaker: Doctor P. Amornritvanich (Bangkok, TH)

Access the full session

New insights into pharmacotherapy for acute heart failure

Speakers: Doctor C. Chimenti, Professor I. Diop, Doctor I. Cunha, Doctor Y. Tamaki, Doctor K. Kam...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources